What to Expect from Pharmacovigilance Services in 2027

Meet Navitas Life Sciences at Pharmacovigilance India 2026 As the pharmaceutical industry embraces artificial intelligence, real-world evidence and in...

Continue reading

PK Studies in Patients: Choosing the Right Study Design for Faster Drug Development

Drug development begins with one fundamental question: How does the body handle a drug and how does the drug affect the body?The answer comes from pha...

Continue reading

Data Science: The Competitive Advantage in Modern Drug Development

Boutique by Design. Outcome-focused by Model. As clinical trials become increasingly complex, sponsors need more than functional support, they need ex...

Continue reading

What Contract Research Partners Are Best for Running Decentralized or Hybrid Clinical Trials?

How biotech companies can identify the right CRO partner to accelerate patient recruitment, improve trial quality, reduce operational burden and deliv...

Continue reading

Why Global Pharma Needs Concierge Governance for Controlled Regulatory Data

Pharmaceutical organizations are facing a new challenge that goes beyond clinical development, pharmacovigilance and regulatory submissions: controlli...

Continue reading

How Pharmacovigilance Consulting Services Build Scalable PV Systems

Bringing a new therapy to market is one of the most significant milestones in a pharmaceutical or biotechnology company's journey. Yet, while organiza...

Continue reading

Full-Service CRO vs FSP: Which Model Is Right for Your Clinical Development Program?

Biotech and pharma companies face increasing pressure to accelerate timelines, manage costs, cater to regulatory changes and maintain quality across g...

Continue reading

How Small Biotechs Can Operate Like Big Pharma Without Big Pharma Budgets

Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile...

Continue reading

25 Years of Navitas Industry Networks Through 25 Voices of Peer Leadership

25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceuti...

Continue reading

Advancing Parkinson’s Disease Research Through Smarter Clinical Trial Partnerships

How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’...

Continue reading

Why End-to-End Clinical Trial Solutions Are Becoming Critical for Global Drug Development

How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the ...

Continue reading

5 Mistakes Biotech Companies Make When Choosing a CRO

Selecting the right clinical research organization (CRO) can determine the success or failure of a biotech company’s clinical program. With inc...

Continue reading

R Programming in the Age of AI: A Pharmaverse Webinar

The conversation around R programming has fundamentally changed. What was once viewed as a niche statistical language, largely confined to academia, h...

Continue reading

SAHPRA Update: pharmaREADY® for eCTD Submissions

SAHPRA Application ID Update 2025: Impact on eCTD Submission and eCTD Publishing The South African Health Products Regulatory Authority (SAHPRA) relea...

Continue reading

The History of Navitas Networks: From a simple platform to the 25th Anniversary

In 2001, a small group of life sciences leaders came together with a simple but unconventional idea, to create a space where industry peers could coll...

Continue reading

From Clinical Safety to Commercial Readiness: A Pharmacovigilance-in-a-Box Solution

Organizations approaching regulatory approval and commercialization face a rapid expansion in pharmacovigilance requirements, moving from development-...

Continue reading

How Navitas’ Ophthalmology Clinical Trials Are Solving Biotech Challenges

Biotech Innovation Meets Clinical Trial Excellence Biotech innovation is advancing rapidly but translating breakthroughs into approved therapies remai...

Continue reading

The Data Backbone of Hybrid Clinical Trials

Turning Regulatory Complexity into Strategic Advantage Hybrid and decentralized models are becoming the default architecture for modern clinical devel...

Continue reading

Real world Evidence Solutions for Foundations

Real-world evidence (RWE) is emerging as a cornerstone of modern clinical development and regulatory strategy for patient-centric innovation. How is r...

Continue reading

Navitas Earns EcoVadis Award for Second Year in a Row

Navitas has been awarded the EcoVadis Bronze Medal for the second consecutive year, showcasing the organization’s commitment to Environmental, ...

Continue reading

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us